Piscidin 1

General Information


DRACP ID  DRACP02083

Peptide Name   Piscidin 1

Sequence  FFHHIFRGIVHVGKTIHRLVTG

Sequence Length  22

UniProt ID  Q8UUG0 

PubChem CID  Not available

Origin  Morone saxatilis (Striped bass) (Perca saxatilis)

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HT-1080 Fibrosarcoma Sarcoma IC50=5.58 µM MTT/MTS assay 24 h, 48 h 1
MDA-MB-231 Breast adenocarcinoma Carcinoma IC50=5.83 µM MTT/MTS assay 24 h, 48 h 1
A549 Lung adenocarcinoma Carcinoma IC50=4.2 µM MTT/MTS assay 24 h, 48 h 1
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma IC50=2.22 µM MTT/MTS assay 24 h, 48 h 1

Hemolytic Activity  Human erythrocytes: 50% Hemolysis=3.12 µg/ml; 100% Hemolysis=25 µg/ml

Normal (non-cancerous) Cytotoxicity  HEK293: LC90=50 µg/ml (>90% cells killed)

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial; Antifungal; Antiviral; Anti-Inflammatory



Structure Information


PDB ID  2MCU  

Predicted Structure  DRACP02083

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C122H187N37O25

Absent amino acids  ACDEMNPQSWY

Common amino acids  H

Mass  294682

Pl  12.52

Basic residues  7

Acidic residues  0

Hydrophobic residues  10

Net charge  7

Boman Index  -1561

Hydrophobicity  45.45

Aliphatic Index  110.45

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 34135370

Title  Copper-binding anticancer peptides from the piscidin family: an expanded mechanism that encompasses physical and chemical bilayer disruption

Doi 10.1038/s41598-021-91670-w

Year  2021

Literature 2

Pubmed ID 31354312

Title  Substitution of lysine for isoleucine at the center of the nonpolar face of the antimicrobial peptide, piscidin-1, leads to an increase in the rapidity of bactericidal activity and a reduction in toxicity

Doi 10.2147/IDR.S195872

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPR_2370

DRACP is developed by Dr.Zheng's team.